Success in large-scale studies could see drug to market by 2012
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Nature Reviews Microbiology: editorial
Related external links
World Health Organization list of malaria vaccine candidates [pdf]
Rights and permissions
About this article
Cite this article
Nayar, A. Malaria vaccine enters phase III clinical trials. Nature (2009). https://doi.org/10.1038/news.2009.517
Published:
DOI: https://doi.org/10.1038/news.2009.517